IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,260,078 | -71.4% | 79,400 | -66.0% | 0.02% | -75.6% |
| Q2 2023 | $4,402,371 | +196.7% | 233,300 | +16.6% | 0.08% | +358.8% |
| Q4 2021 | $1,484,000 | +30.9% | 200,000 | 0.0% | 0.02% | +30.8% |
| Q3 2021 | $1,134,000 | -45.8% | 200,000 | -37.0% | 0.01% | -53.6% |
| Q2 2021 | $2,091,000 | +17.2% | 317,500 | +44.3% | 0.03% | -28.2% |
| Q1 2021 | $1,784,000 | +7.7% | 220,000 | -14.4% | 0.04% | +5.4% |
| Q4 2020 | $1,657,000 | +1269.4% | 257,100 | +414.2% | 0.04% | +516.7% |
| Q3 2019 | $121,000 | -67.2% | 50,000 | -70.6% | 0.01% | -68.4% |
| Q2 2019 | $369,000 | -63.8% | 170,000 | -54.8% | 0.02% | -66.1% |
| Q1 2019 | $1,018,000 | +8.3% | 376,200 | +92.2% | 0.06% | -25.3% |
| Q4 2018 | $940,000 | +28.4% | 195,750 | +153.4% | 0.08% | +87.5% |
| Q3 2018 | $732,000 | +54.4% | 77,250 | +71.7% | 0.04% | -40.3% |
| Q1 2018 | $474,000 | – | 45,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |